37mon MSN
Beam Therapeutics Inc. (BEAM) reports updated data from BEACON Phase 1/2 Trial of Ristoglogene
Beam Therapeutics Inc. (NASDAQ:BEAM) is among the 12 Best Genomics Stocks to Invest In. TheFly reported on December 2, 2025, ...
TipRanks on MSN
Anbio Biotechnology posts higher margins and profits despite revenue dip in first half of 2025
An announcement from Anbio Biotechnology Class A ( ($NNNN) ) is now available. On December 30, 2025, Anbio Biotechnology reported unaudited ...
Arkansas State University welcomed a new class of alumni on Dec. 13 during fall commencement exercises, as 2,335 degrees were ...
Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel payloads today ...
The Class 8 and Class 12 examinations begin February 17, 2026 while the Class 10 exam begins March 6, 2026. The Class 10 and ...
According to academic experts, the Science paper in the 2026 board exams is expected to be relatively more challenging due to ...
Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial ...
Harvard Medical School researchers have uncovered crucial insights into how an emerging class of antiviral drugs works.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results